Handelsbanken Fonder AB Purchases 8,700 Shares of DaVita Inc. (NYSE:DVA)

Handelsbanken Fonder AB increased its position in DaVita Inc. (NYSE:DVA - Free Report) by 108.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 16,700 shares of the company's stock after buying an additional 8,700 shares during the quarter. Handelsbanken Fonder AB's holdings in DaVita were worth $1,749,000 at the end of the most recent reporting period.

Several other large investors have also bought and sold shares of DVA. Hanseatic Management Services Inc. purchased a new position in DaVita during the 3rd quarter worth approximately $36,000. FinTrust Capital Advisors LLC raised its position in DaVita by 242.3% during the third quarter. FinTrust Capital Advisors LLC now owns 712 shares of the company's stock valued at $67,000 after buying an additional 504 shares during the period. Tacita Capital Inc purchased a new stake in DaVita in the 3rd quarter worth about $118,000. Federated Hermes Inc. boosted its position in DaVita by 1,284.4% during the 3rd quarter. Federated Hermes Inc. now owns 1,246 shares of the company's stock worth $118,000 after acquiring an additional 1,156 shares during the period. Finally, CENTRAL TRUST Co increased its holdings in shares of DaVita by 93.3% in the 3rd quarter. CENTRAL TRUST Co now owns 1,448 shares of the company's stock valued at $137,000 after purchasing an additional 699 shares during the period. Institutional investors own 90.12% of the company's stock.

Wall Street Analysts Forecast Growth

DVA has been the topic of a number of research analyst reports. Barclays assumed coverage on shares of DaVita in a research report on Wednesday, March 6th. They set an "equal weight" rating and a $133.00 price objective on the stock. UBS Group increased their price objective on DaVita from $113.00 to $134.00 and gave the stock a "buy" rating in a report on Wednesday, February 14th. TheStreet raised DaVita from a "c+" rating to a "b-" rating in a research report on Wednesday, February 7th. StockNews.com raised DaVita from a "buy" rating to a "strong-buy" rating in a research report on Thursday. Finally, Truist Financial lifted their price target on DaVita from $130.00 to $135.00 and gave the company a "hold" rating in a report on Tuesday, February 20th. Two equities research analysts have rated the stock with a hold rating, one has issued a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, DaVita currently has an average rating of "Moderate Buy" and a consensus price target of $118.50.

Insider Activity at DaVita

In other DaVita news, CEO Javier Rodriguez sold 67,603 shares of the firm's stock in a transaction that occurred on Monday, February 26th. The stock was sold at an average price of $126.11, for a total value of $8,525,414.33. Following the sale, the chief executive officer now owns 488,697 shares of the company's stock, valued at approximately $61,629,578.67. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In other news, CEO Javier Rodriguez sold 67,603 shares of the business's stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $126.11, for a total transaction of $8,525,414.33. Following the transaction, the chief executive officer now owns 488,697 shares in the company, valued at approximately $61,629,578.67. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, COO Michael David Staffieri sold 29,488 shares of the stock in a transaction dated Wednesday, February 21st. The shares were sold at an average price of $119.81, for a total transaction of $3,532,957.28. Following the completion of the sale, the chief operating officer now owns 37,687 shares of the company's stock, valued at approximately $4,515,279.47. The disclosure for this sale can be found here. In the last three months, insiders have sold 134,540 shares of company stock worth $16,551,071. 1.40% of the stock is owned by insiders.

DaVita Stock Up 0.6 %

NYSE DVA traded up $0.74 during trading on Friday, hitting $133.51. 477,673 shares of the company traded hands, compared to its average volume of 478,110. DaVita Inc. has a 12 month low of $71.51 and a 12 month high of $141.54. The business has a fifty day simple moving average of $132.12 and a 200 day simple moving average of $110.85. The company has a market capitalization of $11.71 billion, a P/E ratio of 18.04, a PEG ratio of 1.19 and a beta of 1.04. The company has a current ratio of 1.19, a quick ratio of 1.13 and a debt-to-equity ratio of 6.65.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings data on Tuesday, February 13th. The company reported $1.87 earnings per share for the quarter, beating analysts' consensus estimates of $1.53 by $0.34. DaVita had a return on equity of 64.42% and a net margin of 5.70%. The business had revenue of $3.15 billion for the quarter, compared to the consensus estimate of $3.01 billion. During the same period last year, the business earned $1.11 EPS. The firm's revenue was up 7.8% compared to the same quarter last year. As a group, sell-side analysts predict that DaVita Inc. will post 9.23 EPS for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.